In the latest trading session,, 57.37 million SpringWorks Therapeutics Inc (NASDAQ:SWTX) shares changed hands as the company’s beta touched 0.78. With the company’s most recent per share price at $46.12 changing hands around $1.4 or 3.14% at last look, the market valuation stands at $3.46B. SWTX’s current price is a discount, trading about -34.43% off its 52-week high of $62.00. The share price had its 52-week low at $28.21, which suggests the last value was 38.83% up since then. When we look at SpringWorks Therapeutics Inc’s average trading volume, we note the 10-day average is 3.14 million shares, with the 3-month average coming to 2.76 million.
Analysts gave the SpringWorks Therapeutics Inc (SWTX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.17. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended SWTX as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. SpringWorks Therapeutics Inc’s EPS for the current quarter is expected to be -0.73.
SpringWorks Therapeutics Inc (NASDAQ:SWTX) trade information
Instantly SWTX is in green as seen in intraday trades today. With action 24.46%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 27.66%, with the 5-day performance at 24.46% in the green. However, in the 30-day time frame, SpringWorks Therapeutics Inc (NASDAQ:SWTX) is -2.87% down. Looking at the short shares, we see there were 7.92 million shares sold at short interest cover period of 3.79 days.
The consensus price target for the stock as assigned by Wall Street analysts is 78, meaning bulls need an upside of 40.87% from its recent market value. According to analyst projections, SWTX’s forecast low is 78 with 78 as the target high. To hit the forecast high, the stock’s price needs a -69.12% plunge from its current level, while the stock would need to soar -69.12% for it to hit the projected low.
SpringWorks Therapeutics Inc (SWTX) estimates and forecasts
Year-over-year growth is forecast to reach 82.83% up from the last financial year.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 68.06M. 4 analysts are of the opinion that SpringWorks Therapeutics Inc’s revenue for the current quarter will be 76.84M. The company’s revenue for the corresponding quarters a year ago was 21.01M and 59.73M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 223.99%. The estimates for the next quarter sales put growth at 28.64%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -24.25%. The 2025 estimates are for SpringWorks Therapeutics Inc earnings to increase by 34.95%.
SWTX Dividends
SpringWorks Therapeutics Inc is expected to release its next quarterly earnings report on 2025-Feb-19.
SpringWorks Therapeutics Inc (NASDAQ:SWTX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.27% of SpringWorks Therapeutics Inc shares while 112.62% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 114.07%. There are 112.62% institutions holding the SpringWorks Therapeutics Inc stock share, with FMR LLC the top institutional holder. As of 2024-06-30, the company held 14.9922% of the shares, roughly 11.11 million SWTX shares worth $418.6 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 8.8294% or 6.54 million shares worth $246.53 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jan 31, 2025 were Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 3.56 shares estimated at $164.12 million under it, the former controlled 4.74% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 3.04% of the shares, roughly 2.28 shares worth around $105.14 million.
